NO164958C - Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering. - Google Patents

Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.

Info

Publication number
NO164958C
NO164958C NO841372A NO841372A NO164958C NO 164958 C NO164958 C NO 164958C NO 841372 A NO841372 A NO 841372A NO 841372 A NO841372 A NO 841372A NO 164958 C NO164958 C NO 164958C
Authority
NO
Norway
Prior art keywords
independent
dipyridamol
preparations
procedure
preparation
Prior art date
Application number
NO841372A
Other languages
English (en)
Other versions
NO841372L (no
NO164958B (no
Inventor
Jung-Yong Park
Jerzy Debski
Kieran G Mooney
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of NO841372L publication Critical patent/NO841372L/no
Publication of NO164958B publication Critical patent/NO164958B/no
Publication of NO164958C publication Critical patent/NO164958C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
NO841372A 1983-04-08 1984-04-06 Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering. NO164958C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (3)

Publication Number Publication Date
NO841372L NO841372L (no) 1984-10-09
NO164958B NO164958B (no) 1990-08-27
NO164958C true NO164958C (no) 1990-12-05

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
NO841372A NO164958C (no) 1983-04-08 1984-04-06 Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.

Country Status (20)

Country Link
EP (1) EP0121901B1 (no)
JP (1) JPS6034906A (no)
KR (1) KR880002139B1 (no)
AT (1) ATE32980T1 (no)
AU (1) AU570446B2 (no)
CA (1) CA1219216A (no)
DD (1) DD222496A5 (no)
DE (1) DE3469848D1 (no)
DK (1) DK166259C (no)
ES (1) ES531346A0 (no)
FI (1) FI82604C (no)
GR (1) GR81907B (no)
HU (1) HU191542B (no)
IE (1) IE57220B1 (no)
IL (1) IL71458A (no)
NO (1) NO164958C (no)
NZ (1) NZ207768A (no)
PH (1) PH21585A (no)
PT (1) PT78380B (no)
ZA (1) ZA842562B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
CN102198273A (zh) * 2005-08-22 2011-09-28 诺瓦提斯公司 包含pH依赖性药物、pH调节剂和阻滞剂的药物组合物
JP5111517B2 (ja) 2006-12-13 2013-01-09 エフ．ホフマン−ラ ロシュ アーゲー バルガンシクロビルの粉末製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
FI841369A0 (fi) 1984-04-06
FI841369A (fi) 1984-10-09
DD222496A5 (de) 1985-05-22
DK166259B (da) 1993-03-29
AU570446B2 (en) 1988-03-17
PT78380B (en) 1986-08-14
NO841372L (no) 1984-10-09
FI82604C (fi) 1991-04-10
DK181084A (da) 1984-10-09
DK166259C (da) 1993-08-23
AU2660984A (en) 1984-10-11
CA1219216A (en) 1987-03-17
IE840856L (en) 1984-10-08
PT78380A (en) 1984-05-01
NZ207768A (en) 1987-02-20
GR81907B (no) 1984-12-12
HUT34345A (en) 1985-03-28
JPH0521892B2 (no) 1993-03-25
ATE32980T1 (de) 1988-04-15
KR880002139B1 (ko) 1988-10-17
KR840008588A (ko) 1984-12-17
IL71458A (en) 1987-09-16
HU191542B (en) 1987-03-30
EP0121901B1 (en) 1988-03-16
PH21585A (en) 1987-12-11
JPS6034906A (ja) 1985-02-22
DK181084D0 (da) 1984-04-06
FI82604B (fi) 1990-12-31
DE3469848D1 (en) 1988-04-21
NO164958B (no) 1990-08-27
IL71458A0 (en) 1984-07-31
ES8601687A1 (es) 1985-11-01
IE57220B1 (en) 1992-06-03
EP0121901A1 (en) 1984-10-17
ZA842562B (en) 1985-12-24
ES531346A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
IL83510A (en) Pharmaceutical compositions containing dipyridamole or mopidamol and o-acetylsalicylic acid or salts thereof and their preparation
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
IL83032A (en) Pharmaceutical compositions containing calcium salts and their preparation
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
NO164958C (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig, regulert frigjoering.
DE3067784D1 (en) 2-hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them
FR2515038B1 (fr) A titre de medicaments, certains derives de l'acide 4-phenyl 4-oxo 2-butenoique et compositions les renfermant
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
IL93590A0 (en) Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them
ZA882096B (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2-(bipranole)and its acid addition salts for use as active therapeutic substances
ZA818149B (en) 2-hydroxy-5-(2',4'-difluorophenyl)-benzoic acid derivatives,methods for their preparation,use thereof as pharmacologically active agents and pharmaceutical compositions containing them
JPS5573608A (en) Stable diagnosing drug for radioactive technetium labeling
SG144094G (en) Oral formulation of buspirone and salts thereof
IT1164217B (it) Sali di calcio di amminoacidi o di loro derivati,aventi attivita' terapeutica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IL78136A (en) Indole derivatives,acid addition salts thereof,process for their preparation and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN OCTOBER 2003